Northern Trust’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,780
| Closed | -$24K | – | 4728 |
|
|
2022
Q3 | $24K | Hold |
8,780
| – | – | ﹤0.01% | 4520 |
|
|
2022
Q2 | $40K | Hold |
8,780
| – | – | ﹤0.01% | 4471 |
|
|
2022
Q1 | $63K | Hold |
8,780
| – | – | ﹤0.01% | 4481 |
|
|
2021
Q4 | $59K | Hold |
8,780
| – | – | ﹤0.01% | 4563 |
|
|
2021
Q3 | $102K | Hold |
8,780
| – | – | ﹤0.01% | 4390 |
|
|
2021
Q2 | $164K | Buy |
8,780
+4,860
| +124% | +$90.6K | ﹤0.01% | 4223 |
|
|
2021
Q1 | $91K | Buy |
+3,920
| New | +$99.3K | ﹤0.01% | 4298 |
|
|
2019
Q4 | – | Sell |
-217
| Closed | -$3K | – | 4312 |
|
|
2019
Q3 | $3K | Hold |
217
| – | – | ﹤0.01% | 4228 |
|
|
2019
Q2 | $5K | Hold |
217
| – | – | ﹤0.01% | 4238 |
|
|
2019
Q1 | $8K | Hold |
217
| – | – | ﹤0.01% | 4186 |
|
|
2018
Q4 | $8K | Hold |
217
| – | – | ﹤0.01% | 4217 |
|
|
2018
Q3 | $34K | Hold |
217
| – | – | ﹤0.01% | 4180 |
|
|
2018
Q2 | $29K | Hold |
217
| – | – | ﹤0.01% | 4186 |
|
|
2018
Q1 | $54K | Hold |
217
| – | – | ﹤0.01% | 4072 |
|
|
2017
Q4 | $60K | Sell |
217
-15
| -6% | -$5.72K | ﹤0.01% | 4051 |
|
|
2017
Q3 | $94K | Buy |
232
+18
| +8% | +$9.38K | ﹤0.01% | 3969 |
|
|
2017
Q2 | $127K | Buy |
214
+81
| +61% | +$47.4K | ﹤0.01% | 3917 |
|
|
2017
Q1 | $82K | Buy |
133
+48
| +56% | +$17.1K | ﹤0.01% | 4000 |
|
|
2016
Q4 | $17K | Buy |
85
+3
| +4% | +$682 | ﹤0.01% | 4113 |
|
|
2016
Q3 | $22K | Hold |
82
| – | – | ﹤0.01% | 4096 |
|
|
2016
Q2 | $25K | Hold |
82
| – | – | ﹤0.01% | 4095 |
|
|
2016
Q1 | $35K | Hold |
82
| – | – | ﹤0.01% | 4072 |
|
|
2015
Q4 | $41K | Hold |
82
| – | – | ﹤0.01% | 4083 |
|
|
2015
Q3 | $97K | Buy |
82
+12
| +17% | +$18.4K | ﹤0.01% | 3943 |
|
|
2015
Q2 | $124K | Sell |
70
-15
| -18% | -$23.3K | ﹤0.01% | 3901 |
|
|
2015
Q1 | $99K | Hold |
85
| – | – | ﹤0.01% | 4041 |
|
|
2014
Q4 | $85K | Hold |
85
| – | – | ﹤0.01% | 4005 |
|
|
2014
Q3 | $114K | Hold |
85
| – | – | ﹤0.01% | 3999 |
|
|
2014
Q2 | $144K | Buy |
85
+1
| +1% | +$1.9K | ﹤0.01% | 3929 |
|
|
2014
Q1 | $191K | Sell |
84
-9
| -10% | -$23K | ﹤0.01% | 3801 |
|
|
2013
Q4 | $193K | Buy |
+93
| New | +$201K | ﹤0.01% | 3728 |
|
Other funds holding VYNT
MC
HF
VF
Northern Trust's VYNT Position: Q4 2022 in Review
Northern Trust sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2022, closing a stake of 8,780 shares — an estimated $24K sold.
Northern Trust first reported a position in VYNT in Q4 2013 and held it in 31 quarters. The position peaked at $193K in Q4 2013. 17 funds tracked by Wall St. Rank hold VYNT as of Q4 2022.
- Northern Trust reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Northern Trust sold 8,780 Vyant Bio, Inc. Common Stock shares in Q4 2022, an estimated $24K.
- Northern Trust first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 31 quarters.
- Northern Trust's Vyant Bio, Inc. Common Stock position peaked at $193K in Q4 2013.
- 17 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2022.
Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.